The effect of paclitaxel‐loaded nanoparticles with radiation on hypoxic MCF‐7 cells
暂无分享,去创建一个
[1] P. Couvreur,et al. Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.
[2] Robert Gurny,et al. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. , 2002, International journal of pharmaceutics.
[3] D. Katti,et al. Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[4] Gordon L. Amidon,et al. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent , 1997, Pharmaceutical Research.
[5] G. de Rosa,et al. Primary Ewing's sarcoma of the maxilla, a rare and curable localization: report of two new cases, successfully treated by radiotherapy and systemic chemotherapy. , 1996, Cancer letters.
[6] G. Rosen,et al. Surgical indications for Ewing's sarcoma of the pelvis , 1995, Cancer.
[7] Kazunori Kataoka,et al. Block copolymer micelles as long-circulating drug vehicles , 1995 .
[8] L. Peters,et al. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. , 1995, International journal of radiation oncology, biology, physics.
[9] R. Jain,et al. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.
[10] E. Eisenhauer,et al. Clinical toxicities encountered with paclitaxel (Taxol). , 1993, Seminars in oncology.
[11] E. Hall,et al. Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.
[12] D. Ettinger,et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. , 1989 .
[13] J M Brown,et al. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. , 1979, The British journal of radiology.
[14] A J Dembo,et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. , 1978, The British journal of cancer. Supplement.
[15] B. Brown,et al. Response of mouse intestine to neutrons and gamma rays in relation to dose fractionation and division cycle , 1974, Cancer.
[16] A. Howes. An estimation of changes in the proportions and absolute numbers of hypoxic cells after irradiation of transplanted C3H mousemammary tumours. , 1969, The British journal of radiology.
[17] W. K. Sinclair,et al. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. , 1966, Radiation research.
[18] L. Tolmach,et al. X-Ray Sensitivity and DNA Synthesis in Synchronous Populations of HeLa Cells , 1963, Science.
[19] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[20] M. Horsman,et al. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review. , 1995, Acta oncologica.
[21] L. Norton,et al. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity , 1994, International journal of clinical & laboratory research.
[22] S. Arbuck. Taxol (paclitaxel): future directions. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] D. Bissett,et al. Taxol and taxotere--current status and future prospects. , 1993, European journal of cancer.
[24] M. Shenoy,et al. Chemical radiosensitizers in cancer therapy. , 1992, Cancer investigation.
[25] E. Hall,et al. Taxol: a novel radiation sensitizer. , 1992, International journal of radiation oncology, biology, physics.